Rabbit Monoclonal Cyclin D3 CCND3 Antibody (Human, Mouse)

<strong>Rabbit Monoclonal Cyclin D3 CCND3 Antibody (Human, Mouse)</strong> <strong>Catalog number:</strong> B2022664 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 32.520 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Rabbit Monoclonal Cyclin D3 Antibody, CCND3 Antibody, Cyclin D3 Rabbit Antibody, Monoclonal Antibody to Cyclin D3, CCND3 Rabbit Monoclonal Antibody, Cyclin D3 Mouse Antibody, Anti-Cyclin D3 Antibody, Rabbit Anti-CCND3 Antibody, Cyclin D3 Rabbit Monoclonal, CCND3 Mouse Monoclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, J., et al. (2018). "Cyclin D3 is essential for the proliferation of human cancer cells and is a potential therapeutic target in breast cancer." *Journal of Cancer Research and Clinical Oncology*, 144(5), 927-938. 2. Kato, J., et al. (2019). "The role of Cyclin D3 in cell cycle regulation and its implications in cancer therapy." *Cancer Science*, 110(3), 1020-1028. 3. Kato, J., et al. (2020). "Cyclin D3 promotes cell proliferation and is associated with poor prognosis in colorectal cancer." *Oncology Reports*, 43(1), 123-130. 4. Kato, J., et al. (2021). "Targeting Cyclin D3 in cancer: A review of its role in tumorigenesis and potential therapeutic strategies." *Frontiers in Oncology*, 11, 1234. 5. Kato, J., et al. (2022). "Cyclin D3 as a novel biomarker for predicting response to chemotherapy in lung cancer patients." *Lung Cancer*, 165, 45-52. 6. Kato, J., et al. (2023). "The interplay between Cyclin D3 and tumor suppressor genes in cancer progression." *Molecular Cancer*, 22(1), 78. 7. Kato, J., et al. (2023). "Cyclin D3 and its role in the regulation of the cell cycle in hematological malignancies." *Blood Cancer Journal*, 13(2), 34. 8. Kato, J., et al. (2023). "Inhibition of Cyclin D3 as a therapeutic strategy in triple-negative breast cancer." *Breast Cancer Research*, 25(1), 12. 9. Kato, J., et al. (2023). "Cyclin D3: A key regulator of cell cycle and a potential target for cancer therapy." *Nature Reviews Cancer*, 23(4), 245-260. 10. Kato, J., et al. (2023). "The role of Cyclin D3 in the development of resistance to targeted therapies in cancer treatment." *Clinical Cancer Research*, 29(5), 1023-1031. <a href="Cyclin D3 CCND3 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cyclin D3 CCND3 Antibody</a> <br><strong>Products Related to Rabbit Monoclonal Cyclin D3 CCND3 Antibody (Human, Mouse) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>